Evidence map›Paper›PMID 42284597›Full record

ArticleCancer research communications2026

Stromal Cell Subsets Modulate T-cell Infiltration in Early Breast Cancer.

Julia Chen, Hanyun Zhang, Travis Ruan, Sunny Z Wu, Iveta Slapetova, Ewan Millar, Peter H Graham, Jodi Lynch, Lois H Browne, Elgene Lim and 1 more

Abstract read
In one paragraph

Article in Cancer research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julia ChenCancer Ecosystems Program, Garvan Institute of Medical Research, Sydney, Australia.ORCID 0000-0003-1278-7763
Hanyun ZhangCancer Ecosystems Program, Garvan Institute of Medical Research, Sydney, Australia.ORCID 0000-0002-4140-7881
Travis RuanCancer Ecosystems Program, Garvan Institute of Medical Research, Sydney, Australia.ORCID 0000-0001-9980-0283
Sunny Z WuImmunology Discovery and Oncology Bioinformatics, Genentech, South San Francisco, California.ORCID 0000-0002-6153-0449
Iveta SlapetovaKatharina Gaus Light Microscopy Facility, University of New South Wales, Sydney, Australia.ORCID 0009-0007-6914-8088
Ewan MillarSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.ORCID 0000-0002-9778-3253
Peter H GrahamSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.ORCID 0000-0002-4957-4895
Jodi LynchSt George Cancer Care Centre, St George Hospital, Sydney, Australia.ORCID 0000-0001-9598-7159
Lois H BrowneSchool of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.ORCID 0000-0003-3298-0333
Elgene LimCancer Ecosystems Program, Garvan Institute of Medical Research, Sydney, Australia.ORCID 0000-0001-8065-8838
Alexander SwarbrickCancer Ecosystems Program, Garvan Institute of Medical Research, Sydney, Australia.ORCID 0000-0002-3051-5676

Funding

Cancer Council NSW (Cancer Council New South Wales) 10Cancer Council NSW (Cancer Council New South Wales) RG22-National Breast Cancer Foundation (NBCF)National Health and Medical Research Council (NHMRC)
6 · The paper itself

Abstract

Recent studies of the tumor microenvironment (TME) have elucidated the heterogeneity of stromal cells, with increasing evidence suggesting that stromal subsets play an important role in regulating antitumor immunity in breast cancer. However, the functional diversity of these cells within the tumor-immune microenvironment and how they interact with immune cells in a spatial and clinical context remain poorly understood. We performed multiplex immunofluorescence on tumor microarrays from two cohorts consisting of 591 patients with breast cancer to assess the abundance and spatial co-localization of stromal and immune subsets and their correlation with clinicopathologic features and patient outcomes. We found that stromal cells were spatially distinct. A perivascular-like subset that was disseminated throughout the stroma rather than restricted to vessel-adjacent regions was enriched in an immune-cold environment and associated with T-cell exclusion. An inflammatory-like cancer-associated fibroblast subset was associated with segregation of T cells from cancer cells. Our findings highlight the differential impact of stromal subsets on immune infiltration and activation within the breast cancer TME with potential implications for patient outcomes. SIGNIFICANCE: This study characterized spatially defined interactions between stromal and immune subsets in large clinical cohorts of early breast cancer. Findings from this study will fill gaps in current knowledge in how diverse stromal cell subsets, particularly novel subsets, interact with immune cells in a clinically relevant context.

Indexed as

Breast NeoplasmsLymphocytes, Tumor-InfiltratingStromal CellsT-LymphocytesTumor MicroenvironmentAdultFemaleHumansMiddle Aged

Identifiers

PMID42284597
PMCPMC13343345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.